Placebo to BI 765423, BI 765423
1493-0002
Phase 2 small_molecule active
Quick answer
Placebo to BI 765423, BI 765423 for Idiopathic Pulmonary Fibrosis (IPF) is a Phase 2 program (small_molecule) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- Idiopathic Pulmonary Fibrosis (IPF)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active